Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
ACHL
Achilles Therapeutics plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for ACHL
Full ACHL profile on Quantisnow Follow ACHL and get a push notification the moment its next story breaks.